[1]汪 莉,杜红旭,周正国,等.攻癌固真汤联合吉非替尼治疗肺癌气虚血瘀证疗效及对患者血流状态的影响[J].陕西中医,2021,(3):338-340.[doi:DOI:10.3969/j.issn.1000-7369.2020.03.017]
　WANG Li,DU Hongxu,ZHOU Zhengguo,et al.Clinical effect of Gong'ai Guzhen decoction combined with gefitinib in treating lung cancer with Qixu Xueyu syndrome and affect blood flow state[J].,2021,(3):338-340.[doi:DOI:10.3969/j.issn.1000-7369.2020.03.017]
点击复制

攻癌固真汤联合吉非替尼治疗肺癌气虚血瘀证疗效及对患者血流状态的影响
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2021年3期
页码:
338-340
栏目:
临床研究
出版日期:
2021-03-09

文章信息/Info

Title:
Clinical effect of Gong'ai Guzhen decoction combined with gefitinib in treating lung cancer with Qixu Xueyu syndrome and affect blood flow state
作者:
汪 莉; 杜红旭; 周正国; 李 铁
(大连市第二人民医院肿瘤科,辽宁 大连 116011)
Author(s):
WANG Li; DU Hongxu; ZHOU Zhengguo; LI Tie
(Department of Oncology,Dalian Second People's Hospital,Dalian 116011,China)
关键词:
肺癌;  气虚血瘀证;  攻癌固真汤;  生活质量;  血流状态
Keywords:
Lung cancer;  Qixu Xueyu syndrome;  Gong'ai Guzhen decoction;  Quality of life;  Blood flow state
分类号:
R 734.2
DOI:
DOI:10.3969/j.issn.1000-7369.2020.03.017
文献标志码:
A
摘要:
目的:分析攻癌固真汤治疗肺癌气虚血瘀证治疗效果及对患者生活质量、血流状态的影响。方法:纳入肺癌气虚血瘀证患者127例,随机分为观察组(n=75)和对照组(n=52)。对照组给予吉非替尼口服治疗,观察组在对照组基础上联合攻癌固真汤治疗。观察两组患者的治疗效果、生活质量以及血液流变学包括纤维蛋白原、全血低切黏度、全血高切黏度、红细胞聚集指数及血浆黏度等变化。结果:对照组临床总有效率为67.31%,低于观察组的89.33%,差异具有统计学意义(P<0.05)。观察组和对照组治疗后卡氏评分均增加,且观察组高于对照组,差异均有统计学意义(P<0.05)。与治疗前比较,两组各项血液流变学指标明显降低,且观察组低于对照组,差异有统计学意义(均P<0.05)。对照组不良反应发生率为19.23%,观察组为18.67%,组间比较差异无统计学意义(P>0.05)。结论:攻癌固真汤联合吉非替尼治疗肺癌气虚血瘀证疗效较好,可有效提高患者生活质量,改善血流状态,且不良反应较少。
Abstract:
Objective:To analyze the effect of Gong'ai Guzhen decoction on quality of life and blood flow in the treatment of lung cancer with Qixu Xueyu syndrome.Methods:127 patients with lung cancer of Qixu Xueyu syndrome were divided into observation group(n=75)and control group(n=52).The control group was treated with gefitinib orally,and the observation group was treated with Gong'ai Guzhen decoction.Observe the treatment effect,that in quality of life and hemorheology include fibrinogen,whole blood low shear viscosity,whole blood high viscosity,erythrocyte aggregation index and plasma viscosity.Results:The effective rate of clinical treatment was 67.31% in the control group,which was significantly lower than 89.33% in the observation group,difference statistically significant(P<0.05).Cargill score of the observation group and the control group increased significantly,and the observation group was higher than that in the control group,statistically significant differences(P<0.05).Compared with before treatment,various hemorheology indexes in both groups were significantly reduced,difference statistically significant in the observation group compared with the control group(all P<0.05).The incidence of adverse reactions was 19.23% in the control group and 18.67% in the observation group,no significant difference(P>0.05).Conclusion:Gong'ai Guzhen decoction combined with gefitinib has significant effect on the treatment of lung cancer with Qixu Xueyu syndrome,effectively improve the quality of life and the blood flow status in patients.The adverse reactions was also lower.

参考文献/References:

[1] 刘海涛,衣秀秀,田建辉.肺癌中西医抗凝治疗研究进展[J].陕西中医,2020,41(1):127-130.
[2] 任宝中,李 媛.益气化瘀方配合化疗治疗晚期非小细胞肺癌临床研究[J].陕西中医,2019,40(8):1036-1040.
[3] 冯谢敏,赵 红,崔 洁,等.同步放化疗治疗局部晚期非小细胞肺癌疗效观察[J].陕西医学杂志,2016,45(9):1126-1128.
[4] 王双双.攻癌固真汤对气虚血瘀证肺癌患者血液流变学的影响[J].亚太传统医药,2016,12(1):118-119.
[5] 国家中医药管理局.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:290-292.
[6] 叶 波,赵 珩.第八版国际肺癌TNM分期修订稿解读[J].中国肺癌杂志,2016,19(6):337-342.
[7] 朱 盼,李泽庚,董昌武.肺癌中医证型研究概况[J].实用中医内科杂志,2017,31(3):91-93.
[8] 高丽霞.益气祛瘀丸治疗气虚血瘀型缺血性中风46例临床观察[J].中华中医药学刊,2015,33(2):483-485.
[9] 刘婷婷,谭 楠,白 璐.痰热清联合左氧氟沙星对老年肺炎患者血清炎症因子水平及肺功能的影响[J].陕西中医,2019,40(9):1180-1182.
[10] 董 强,刘桂芹,刘建新,等.血府逐瘀汤加味治疗中晚期小细胞肺癌临床研究[J].河南中医,2014,8(9):1758-1760.
[11] 李君艳,陈国荣.肺癌患者凝血指标与临床特征的关系[J].陕西医学杂志,2019,48(6):718-721.
[12] 马明铭,李 芳,杨 慧,等.痰热清注射液对支气管扩张患者FEV1、FVC及PEF水平的影响[J].陕西中医,2019,40(10):1361-1363.
[13] 叶兴涛.肺癌瘀血舌质瘀血液流变学变化的相关性分析[J].中国中医药科技,2012,19(3):196,206.
[14] 王 维.攻癌固真汤对气虚血瘀证肺癌患者血液流变学的影响[J].中成药,2013,35(10):2113-2115.
[15] 汪 莉,李 铁,杜红旭.化湿解毒法治疗慢性原发性血小板减少性紫癜湿热蕴毒证的临床研究[J].中国中医药现代远程教育,2018,16(6):110-112.
[16] 康 明,张宁苏,王晓东.晚期肺癌患者临床特征及中药运用规律分析[J].云南中医中药杂志,2020,41(5):38-41.

相似文献/References:

[1]刘海涛 ,衣秀秀,田建辉△.肺癌中西医抗凝治疗研究进展*[J].陕西中医,2020,(1):127.
[2]邵翠丽,周晋华△,杨勤军,等.周晋华运用环磷酰胺联合中药紫杉治疗晚期肺癌经验*[J].陕西中医,2020,(2):223.
　SHAO Cuili,ZHOU Jinhua,YANG Qinjun,et al.ZHOU Jinhua treats advanced lung cancer with cyclophosphamide and purple shirt[J].,2020,(3):223.
[3]梁春玲,刘祖发△,张辰浩,等.揿针治疗不稳定型心绞痛介入术后心肌损伤临床研究*[J].陕西中医,2020,(3):383.
　LIANG Chunling,LIU Zufa,ZHANG Chenhao,et al.Clinical study on the improvement of myocardial injury after PCI in patients with unstable angina pectoris by pressing needle[J].,2020,(3):383.
[4]王 霞,甘琴霞△,李 娟.益气化瘀盆炎汤加减治疗盆腔炎气虚血瘀证疗效及对患者血液微循环的影响*[J].陕西中医,2020,(12):1722.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.011]
　WANG Xia,GAN Qinxia,LI Juan..Effect of modified Yiqi Huayu Penyan decoction on treatment of pelvic inflammation of Qixu Xueyu syndrome and its influence on blood microcirculation[J].,2020,(3):1722.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.011]
[5]刘 薇,张玉焕,李 争.芪参益气滴丸对老年气虚血瘀型心力衰竭患者心肌保护、炎症状态的影响[J].陕西中医,2021,(1):37.[doi:DOI:10.3969/j.issn.1000-7369.2020.01.008]
　LIU Wei,ZHANG Yuhuan,LI Zheng.Effects of Qishen Yiqi dropping pills on myocardial protection,inflammatory state and serum cell adhesion molecule level in elderly patients with heart failure caused by qi deficiency and blood stasis[J].,2021,(3):37.[doi:DOI:10.3969/j.issn.1000-7369.2020.01.008]
[6]何旭丽,徐军建.芪归益气活血汤治疗慢性肾衰竭气虚血瘀证疗效及对患者肾血流的影响[J].陕西中医,2021,(1):51.[doi:DOI:10.3969/j.issn.1000-7369.2020.01.012]
　HE Xuli,XU Junjian.Effect of Qigui Yiqi Huoxue decoction in treating chronic renal failure with qi deficiency and blood stasis syndrome and its influence on patients' renal blood flow[J].,2021,(3):51.[doi:DOI:10.3969/j.issn.1000-7369.2020.01.012]
[7]郑 茜,刘远婷,丁甜甜,等.消积抑癌方对Lewis肺癌荷瘤小鼠MMP-2的影响[J].陕西中医,2021,(7):844.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.007]
　ZHENG Qian,LIU Yuanting,DING Tiantian,et al.Effect of Xiaoji Yi'ai recipe on MMP-2 in Lewis lung cancer bearing mice[J].,2021,(3):844.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.007]
[8]刘文佳,刘宗凯,初晓苏,等.山慈菇-王不留行干预肺癌向骨转移过程生物信息学作用机制[J].陕西中医,2021,(9):1302.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.041]
[9]杨 昕,李和根.肺癌辨证分型研究进展[J].陕西中医,2021,(9):1313.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.043]
　YANG Xin,LI Hegen.Progress in syndrome differentiation of lung cancer[J].,2021,(3):1313.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.043]
[10]段国华,叶秋菊,张海燕,等.川芎龙蛭汤联合耳穴电探测贴压治疗脑梗死气虚血瘀证临床研究[J].陕西中医,2022,(9):1200.[doi:DOI:10.3969/j.issn.1000-7369.2022.09.010]
　DUAN Guohua,YE Qiuju,ZHANG Haiyan,et al.Clinical study on Chuanxiong Longzhi decoction combined with auricular point electrical detection and sticking pressure in treatment of cerebral infarction with Qixu Xueyu syndrome[J].,2022,(3):1200.[doi:DOI:10.3969/j.issn.1000-7369.2022.09.010]

备注/Memo

备注/Memo:
基金项目:辽宁省自然科学基金资助项目(20180550957); 辽宁省大连市中医药相关科学研究计划项目(2016Z1008); 辽宁省大连市医学科学研究计划项目(中医药类,20171017)
更新日期/Last Update: 2021-03-08